SYGNIS AG / Key word(s): Capital Increase
14.07.2016 22:34
Disclosure of an inside information according to Article 17 MAR,
transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Ad hoc announcement according to § 17 MAR
---------------------------------------------------------------------------
NOT FOR DISTRIBUTION, PUBLICATION, OR TRANSMISSION IN USA, CANADA, JAPAN
AND AUSTRALIA
SYGNIS AG successfully completes Rights Offering
and Private Placement
- Rights offering successfully completed and private placement
oversubscribed
- Acquisition of Expedeon Holdings Ltd. secured
- Gross proceeds to cover additional cash payments to Expedeon
shareholders and transaction-related expenses mainly
Madrid, Spain and Heidelberg, Germany, 14 July 2016 - SYGNIS AG (Frankfurt:
LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced that the Company
has successfully completed its rights offering and the subsequent private
placement. Through these transactions, including the contribution in kind,
the Company's share capital will increase by EUR 20,538,089.00 from EUR
16,803,891.00 to EUR 37,341,980.00 through the issue of 20,538,089 shares
by way of a rights offering.
Existing shareholders subscribed a total number of 3,016,734 new shares.
Further 1.801.466 shares were placed at a subscription price of EUR 1.10
per share with qualified investors in a subsequent rump placement, which
resulted in gross proceeds of EUR 5.3 million. 15.719.889 remaining shares
will be offered to Expedeon shareholders against contribution in kind.
Gross proceeds from the cash capital increase will be used for transaction-
related expenses, including EUR 1.7 million cash payments to Expedeon
shareholders, one-off integration costs and financing working capital.
**** End of ad hoc announcement ****
For further information, please contact:
SYGNIS AG MC Services AG
Pilar de la Huerta Raimund Gabriel
CEO/CFO Managing Partner
Phone: +34 91 192 36 50 Phone: +49 89 210228 30
Email: pdelahuerta@sygnis.com Email: raimund.gabriel@mc-services.eu
About SYGNIS AG: www.sygnis.com
SYGNIS, headquartered in Germany and Spain, specializes in the development
and commercialization of innovative products for DNA amplification and
sequencing. Based on its proprietary technologies, SYGNIS has developed a
commercial product portfolio addressing key challenges in the fast-growing
fields of molecular biology and next-generation sequencing applications.
Key products include the TruePrime(TM) product line and SensiPhi(R),
licensed to a leading industry partner, for whole genome DNA amplification
and sequencing, as well as the SunScript(TM) Reverse Transcriptase product
family to convert genetic information from RNA molecules back to DNA.
SYGNIS AG is listed on the German Stock Exchange in the Prime Standard
segment (Ticker: LIO1; ISIN: DE000A1RFM03).
### This document is not a securities prospectus and the information
contained herein does not constitute an offer to sell or a solicitation of
an offer to purchase any securities of SYGNIS AG in the Federal Republic of
Germany nor under any other jurisdiction, in particular not where such kind
of offer or solicitation is prohibited or lacks the required permission.
Potential investors in securities of SYGNIS AG are asked to familiarize
themselves with and to observe the respective restrictions.
A decision to invest in the securities of SYGNIS AG should only be made on
the basis of the securities prospectus detailing the public offering of
securities of SYGNIS AG in the Federal Republic of Germany, which, subject
to the approval of the German Federal Financial Supervisory Authority
(BaFin) is anticipated to be published under www.sygnis.com/investors.
The information in this document may not be disseminated outside the
Federal Republic of Germany in particular not in the United States, to U.S.
Persons (as defined in regulation S of the U.S. Securities Act of 1933) or
to publications with a general circulation in the United States with the
exception of a such disclosures or announcements outside the Federal
Republic of Germany which have to be made under the respective mandatory
law. Any person who fails to comply with these restrictions may violate the
security laws of certain jurisdictions, in particular of the United States.
Securities in SYGNIS AG are not publicly offered outside the Federal
Republic of Germany.
Some statements included in this ad hoc announcement, relating neither to
proven financial results nor other historical data, should be viewed as
forward-looking, i.e. not definite. Such statements are mainly predictions
of future results, trends, plans or goals. These statements should not be
considered to be total guarantees since given their very nature they are
subject to known and unknown risks and imponderability and can be affected
by other factors as a consequence of which the actual results, plans and
goals of SYGNIS AG may deviate greatly from the established conclusions or
implied predictions contained in such statements. SYGNIS does not undertake
to publicly update or revise these statements in the light of new
information or future results or for any other reason.###
14.07.2016 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: SYGNIS AG
Waldhofer Str. 104
69123 Heidelberg
Germany
Phone: +49 (0) 6221 3540 125
Fax: +49 (0) 6221 3540 127
E-mail: investors@sygnis.com
Internet: www.sygnis.com
ISIN: DE000A1RFM03
WKN: A1RFM0
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated
Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich,
Stuttgart
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
DGAP-Adhoc: SYGNIS AG successfully completes Rights Offering and Private Placement
| Source: EQS Group AG